Back

Pulmonary hypertension is an adverse risk factor for peri-procedural complications in patients undergoing cardioversion for atrial fibrillation

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Prognosis and outcome in patients with atrial fibrillation Rhythm Control, Cardioversion ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Mouna Kodali

Aurora Sinai Aurora St. Lukes Medical Centers, Milwaukee (United States of America)

7 More presentations in this session

Presentation thumbnail
Cigarette smoking and structural brain deficits in patients with atrial fibrillation
Mr R. Peter (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: ASPIRE (efficacy and safety of apixaban in real-world practice in Korean frail patients with AF)
Miss J. Choi (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
The current and future total health care costs of atrial fibrillation
Doctor R. Sandhu (Calgary, CA)
Abstract Slides Video
Presentation thumbnail
Association of atrial fibrillation burden with rhythm control and stroke prevention interventions among patients with cardiac implantable electronic devices
Doctor G. Peigh (Chicago, US)
Abstract Slides Video
Presentation thumbnail
Risk differences between atrial fibrillation patients with different clinical phenotypes: insights from the French population
Doctor A. Fawzy (Liverpool, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Prognosis and outcome in patients with atrial fibrillation

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources